456 Studies Now Enrolling
A multi-site, open-label, Phase II randomized, controlled trial to compare the efficacy of RO7198457 versus watchful waiting in resected, Stage II (high risk), and Stage III colorectal cancer patients who are ctDNA positive following resection
Study of RO7198457 for Patients Who Have Had Surgery for Stage II and Stage III Colon Cancer
| Sponsor: | BioNTech SE |
| Enrolling: | Male and Female Patients |
| IRB Number: | AAAT4655 |
| U.S. Govt. ID: | NCT04486378 |
| Contact: | Research Nurse Navigator: 212-342-5162 / cancerclinicaltrials@cumc.columbia.edu |
Additional Study Information:
The BNT122-01 research study is testing an investigational medication (RO7198457) for patients who have had surgery for Stage II and Stage III colorectal cancer. The study will look at the safety and effectiveness of an investigational medication for patients who have had surgery for Stage II (high risk) and Stage III colorectal cancer. It will study whether it will lead to a longer period of time before recurrence or spread of cancer compared with watchful waiting.
This study is closed
